Tissue Diagnostics Industry Outlook and Statistics, Segmentation and Forecast to 2022-2030

1
Tissue Diagnostics Market Size Worth USD 8.81
Billion in 2030
Increasing prevalence of cancer is a significant
factor driving global tissue diagnostics market
revenue growth
www.emergenresearch.com
2
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4
Industries We Cater to
www.emergenresearch.com
5
5
Market Summary
The Global Tissue Diagnostics Market size is
expected to reach USD 8.81 Billion at a steady
revenue CAGR of 6.6 in 2030, according to the
latest analysis by Emergen Research. One of the
primary driving factors leading to increased
revenue growth of this market is the increasing
prevalence of cancer. Cancer is the major cause
of mortality worldwide, representing over 10
million deaths in 2020, or roughly one in every
six. Infections that cause cancer, such as Human
Papillomavirus (HPV) as well as hepatitis,
account for around 30 of cancer cases in low-
and lower-middle-income economies. Tissue
diagnostics is a significant component when
making decisions for optimal caregiving.
Patients cannot be treated properly unless an
appropriate diagnosis is made. As a result of the
rising occurrence of various types of cancer
throughout the world, there is a growing need for
tissue diagnostics to help in the treatment
process, driving market revenue growth. Spatial
tissue analysis is one of the most fascinating
fields of biological research right now, and it
goes well beyond the basic tissue pathology that
is routinely used in clinical practice. Many
firms are investigating high multiplex
techniques, which combine and image tens or
hundreds of probes to provide a more
comprehensive nucleic acid or protein profile.
The opportunity is to incorporate some of this
developing knowledge and technique into
diagnostics and create powerful next-generation
tissue diagnostic systems with considerable
throughput and rapidly discover various genomic
and proteomic targets at appropriate resolution
without sacrificing throughput, hence bringing
new technology to the market. Read More
https//www.emergenresearch.com/industry-report/ti
ssue-diagnostics-market
www.emergenresearch.com
6
Market Summary
Some Key Highlights From the Report On 28 May
2021, following regulatory approval in the United
States as a companion diagnostic to aid in the
identification of Non-Small Cell Lung Cancer
(NSCLC) patients who could be eligible for
therapies with LUMAKRASTM (sotorasib), a recently
approved therapy developed and marketed by Amgen
Inc., QIAGEN N.V. announced the expansion of
Companion Diagnostic (CDx) claims for the
therascreen KRAS RGQ PCR Kit (therascreen KRAS
Kit). The consumables segment is expected to
account for the largest revenue share during the
forecast period which is attributed to a
recurrent need for consumables as well as
research and increased production for generating
innovative reagents as well as other consumables.
Sakura Finetek USA, Inc., for example, announced
a significantly expanded reagent and consumables
Catalog for the Tissue-Tek Genie Advanced
Staining System on 30 October 2020. Thus, higher
manufacturing as a result of the ongoing
requirement for consumables in research is
driving market revenue growth. The
Immunohistochemistry (IHC) segment is expected to
account for the largest revenue share during the
forecast period owing to the rising frequency of
cancer diagnosis, favorable reimbursement
policies for IHC-based tests, and new
advancements in IHC. Cell IDx, for example,
announced the availability of new chromogenic
multiplex IHC kits for manual staining of human
FFPE tissue segments on 21 February 2020. This
simple, rapid, out-of-the-box solution enables
researchers to stain, scan, and analyze in a
single day, making it a great complement to their
current fast BOND RX-optimized Chromogenic
Multiplex IHC Kits. Request Free Sample _at_
https//www.emergenresearch.com/request-sample/146
3
www.emergenresearch.com
7
Market Summary
Emergen Research has segmented the global tissue
diagnostics market on the basis of product,
technology, disease, end-use, and region Product
Outlook (Revenue, USD Billion 20192030) Consumab
les Instruments Technology Outlook (Revenue, USD
Billion 20192030) Immunohistochemistry (IHC) In
Situ Hybridization (ISH) Digital Pathology
Workflow Management Special Staining Disease
Outlook (Revenue, USD Billion 20192030) Breast
Cancer Gastric Cancer Lymphoma Prostate
Cancer Non-Small Cell Lung Cancer Others      
               Request customization _at_
https//www.emergenresearch.com/request-for-custom
ization/1463
8
Parameter Details
Market Size Estimation Period 2020-2028
Base Year Considered 2020
Historical Data 2017-2019
Forecast Period 2021-2028
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
9
Regional Share Dynamics
www.emergenresearch.com
10
LATEST PUBLICATIONS
Research Antibodies Market https//www.emergenrese
arch.com/industry-report/research-antibodies-marke
t Next Generation Battlefield Technology
Market https//www.emergenresearch.com/industry-re
port/next-generation-battlefield-technology-market
Prefilled Syringes Market https//www.emergenres
earch.com/industry-report/prefilled-syringes-marke
t Free Space Optics Communication Technology
Market https//www.emergenresearch.com/industry-re
port/free-space-optics-communication-technology-ma
rket Airborne Lidar Market https//www.emergenres
earch.com/industry-report/airborne-lidar-market A
rtificial Intelligence In Radiology
Market https//www.emergenresearch.com/industry-re
port/artificial-intelligence-in-radiology-market
Ground Defense System Market https//www.emergenre
search.com/industry-report/ground-defense-system-m
arket Gut Microbiome Test Market https//www.emer
genresearch.com/industry-report/gut-microbiome-tes
t-market
www.emergenresearch.com
11
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
About Us
www.emergenresearch.com
12
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 [phone]